Clinical Trials Browser

Phase 1 × HER2 Positive Gastric Cancer × Clear all

NCT02378389 2015-03-04

Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer

Phase 1 Unknown

Gastrointestinal

HER2 Positive Gastric Cancer